Leukemia and Lymphoma Society

OrganisationROR

Trials

NCT07029217
Collaborator, Phase 3, Recruiting, 375 people, 19 Jun 2025
NCT06954805
Collaborator, Phase 2, Recruiting, 30 people, 2 May 2025
NCT06429449
Collaborator, Phase 1, Recruiting, 30 people, 28 May 2024
NCT06232655
Collaborator, Phase 2, Active, not recruiting, 10 people, 31 Jan 2024
NCT06158828
Collaborator, Phase 1/2, Recruiting, 68 people, 6 Dec 2023
NCT05536349
Collaborator, Phase 2, Recruiting, 60 people, 10 Sept 2022
NCT04024761
Collaborator, Phase 1, Recruiting, 50 people, 18 Jul 2019
NCT03502577
Collaborator, Phase 1, Terminated, 19 people, 18 Apr 2018
NCT02953509
Collaborator, Phase 1/2, Terminated, 178 people, 2 Nov 2016
NCT02927964
Collaborator, Phase 1/2, Completed, 21 people, 7 Oct 2016
NCT02471911
Collaborator, Phase 1, Completed, 22 people, 15 Jun 2015
NCT02280525
Collaborator, Phase 1, Completed, 8 people, 31 Oct 2014
NCT02279394
Collaborator, Phase 2, Completed, 51 people, 31 Oct 2014
NCT02268851
Collaborator, Phase 1, Completed, 45 people, 20 Oct 2014
NCT02251548
Collaborator, Phase 2, Active, not recruiting, 85 people, 29 Sept 2014
NCT02158858
Collaborator, Phase 1/2, Completed, 336 people, 9 Jun 2014
NCT01898793
Collaborator, Phase 1/2, Terminated, 89 people, 12 Jul 2013
NCT01742988
Collaborator, Phase 1, Completed, 106 people, 6 Dec 2012
NCT01317940
Collaborator, Phase 2, Completed, 76 people, 18 Mar 2011
NCT01162551
Collaborator, Phase 2, Completed, 5 people, 14 Jul 2010